Topic
AI Research
Artificial Intelligence continues to be a primary catalyst for global equity performance, with AI-related indices significantly outperforming the S&P 500 and driving a widening valuation gap between US and global markets. This growth has led to unprecedented concentration in hedge fund portfolios, where crowded Tech longs and record-high gross leverage present significant reversal risks, drawing historical parallels to the mid-1990s Netscape cycle. Beyond public equities, AI adoption is fundamentally reshaping private markets, directing capital toward strategic infrastructure like data centers and defense technology as part of a 'new world order.' In the context of a fragmented global economy, emerging markets are gaining traction as essential hubs for AI manufacturing, supporting attractive outlooks for EM equities through 2026. Additionally, institutional investors are increasingly integrating machine learning quantitative screens into their proprietary methodologies to identify high-yield opportunities in structured products. Collectively, these insights underscore AI's role not just as a thematic tailwind, but as a critical component in both investment infrastructure and geopolitical strategy.
4306 reports available
All reports
Page 70 of 180
AI Volatility Is Back But The Capex Story Still Looks Firm
UBS · Jun 9, 2026
Early Morning Reid
Deutsche Bank · Jun 9, 2026
DBDaily
Deutsche Bank · Jun 9, 2026
Health Care Offers More Than a Defensive Role in Portfolios
UBS · Jun 9, 2026
Hemab Therapeutics Holdings Strategic Interests and Market Opportunity in VWD
Goldman Sachs · Jun 9, 2026
United Kingdom Retail Supermarkets
Goldman Sachs · Jun 9, 2026
Fixed Income Weekly Primer
Raymond James · Jun 9, 2026
Goal Kickstart
Goldman Sachs · Jun 9, 2026
The 720 Japan Tech China Internet And Corporate Strategy Updates
Goldman Sachs · Jun 9, 2026
Global Macro Monthly
TS Lombard · Jun 9, 2026
Update on Leo and Satellite Connectivity
Barclays · Jun 9, 2026
Kiniksa Pharmaceuticals Key Takeaways
Goldman Sachs · Jun 9, 2026
Australian Morning Focus
ANZ · Jun 9, 2026
Sarepta Therapeutics Key Takeaways
Goldman Sachs · Jun 9, 2026
Pfizer 47th Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 9, 2026
GS Sustain: The Reliability Imperative
Goldman Sachs · Jun 9, 2026
BoJ Monetary Policy Meeting Preview
Citi · Jun 9, 2026
Innovation Themes: From Orbit To Open Banking
BlackRock · Jun 9, 2026
Micron Technology Inc. 3Q Preview
Goldman Sachs · Jun 9, 2026
Turkiye Banks Sector Trends
Goldman Sachs · Jun 9, 2026
Teva Pharmaceuticals Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 9, 2026
International Market Intelligence Morning Briefing
J.P. Morgan · Jun 9, 2026
Shoring Up The Indian Rupee – RBI June 2026 Measures
MUFG · Jun 9, 2026
Tandem Diabetes Care Inc. Key Takeaways
Goldman Sachs · Jun 9, 2026